Framingham, MA, United States of America

Robert J Broeze

This inventor holds 1 USPTO granted patent. Top assignee: Collaborative Research, Inc.. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert J Broeze

Introduction

Robert J Broeze is an accomplished inventor based in Framingham, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of thrombolytic therapy. His innovative work has the potential to improve treatment outcomes for patients suffering from thrombotic conditions.

Latest Patents

Robert J Broeze holds a patent for "Two-chain urokinase plasminogen activators for treatment of thrombotic." This patent describes a fibrin-specific two-chain plasminogen activator in a therapeutic dosage form. The invention also includes a method for dissolving clots in vivo by applying this fibrin-specific two-chain plasminogen activator in a therapeutic dosage form. This advancement represents a significant step forward in the treatment of thrombotic diseases.

Career Highlights

Throughout his career, Robert has focused on developing innovative solutions that address critical medical challenges. His work has been recognized for its potential to enhance patient care and improve therapeutic efficacy. With 1 patent to his name, he continues to contribute to the advancement of medical science.

Collaborations

Robert J Broeze has collaborated with Gerald F Vovis, working together to push the boundaries of medical innovation. Their partnership exemplifies the importance of teamwork in the pursuit of groundbreaking inventions.

Conclusion

Robert J Broeze's contributions to medical technology through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…